19-44703354-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000587331.7(CEACAM16):āc.43T>Cā(p.Phe15Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00051 in 1,608,808 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
ENST00000587331.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEACAM16 | NM_001039213.4 | c.43T>C | p.Phe15Leu | missense_variant | 3/7 | ENST00000587331.7 | NP_001034302.2 | |
CEACAM16 | XM_017026795.2 | c.43T>C | p.Phe15Leu | missense_variant | 2/5 | XP_016882284.1 | ||
CEACAM16-AS1 | NR_186815.1 | n.348-4177A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEACAM16 | ENST00000587331.7 | c.43T>C | p.Phe15Leu | missense_variant | 3/7 | 1 | NM_001039213.4 | ENSP00000466561.1 |
Frequencies
GnomAD3 genomes AF: 0.00272 AC: 414AN: 152152Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.000769 AC: 189AN: 245798Hom.: 1 AF XY: 0.000599 AC XY: 80AN XY: 133594
GnomAD4 exome AF: 0.000279 AC: 407AN: 1456538Hom.: 1 Cov.: 32 AF XY: 0.000236 AC XY: 171AN XY: 723544
GnomAD4 genome AF: 0.00272 AC: 414AN: 152270Hom.: 2 Cov.: 32 AF XY: 0.00270 AC XY: 201AN XY: 74468
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 30, 2020 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 20, 2023 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | Phe15Leu in exon 3 of CEACAM16: This variant is not expected to have clinical si gnificance because it has been identified in 0.8% (33/4008) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs114907619). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at